Related Experiment Video
Updated: May 12, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Genomic approaches to chronic lymphocytic leukemia
Ma Reina Improgo1, Jennifer R Brown
1Department of Medical Oncology, Dana-Farber Cancer Institute, CLL Center, Harvard Medical School, Boston, MA 02215, USA.
Hematology/Oncology Clinics of North America
|April 9, 2013
Summary
Genomic tools reveal DNA changes in chronic lymphocytic leukemia (CLL). These findings offer insights into the disease and guide potential new treatments.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy.
- Understanding the genomic landscape of CLL is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent advances in genomic approaches for studying CLL.
- To discuss the clinical relevance of genomic findings in CLL.
Main Methods:
- Analysis of DNA-level lesions using various genomic platforms.
- Summarization of data obtained from high-throughput sequencing and other genomic tools.
Main Results:
- Identification of recurrent and novel genetic alterations in CLL.
- Correlation of specific genomic aberrations with clinical outcomes and disease progression.
Conclusions:
- Genomic approaches have significantly advanced our understanding of CLL pathogenesis.
- Genomic data provides valuable biomarkers for prognosis and therapeutic decision-making in CLL.
